nohealthproblemsnews.com
(HealthDay)—Exercise and/or behavioral treatment interventions may provide clinically meaningful improvements in depression outcomes in adults with type 2 diabetes (T2DM) […] New research updates guidance to clinicians on how best to treat patients with type 2 diabetes who do not respond […] MONDAY, Feb. 25, 2019 — Kratom, or Mitragyna speciosa, exposure is associated with serious medical outcomes, especially as part of […] In a recently published study, Vera Bittner, M.D., professor in the University of Alabama at Birmingham Division of Cardiovascular Disease, […] Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable […] Before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital—whether at home, a doctor’s office or a skilled […] Hispanic infants with critical types of congenital heart disease have worse outcomes in their first year than do their non-Hispanic […] A team of disability researchers has authored a new article that explores the underlying factors for the substantial geographic variation […] The first large U.S. study of cognition in older breast cancer patients found that within the first two years after […] Long-term antiplatelet monotherapy after stenting is safe but does not reduce the risk of death or heart attack compared to […]
Exercise, therapy may improve depression, diabetes outcomes
Research informs best outcomes on type 2 diabetes treatment
Serious Medical Outcomes Reported With Kratom Exposure
Weight cycling does not adversely affect cardiovascular outcomes in women with suspected myocardial ischemia
Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy
Worse outcomes for Hispanic infants with critical congenital heart disease
Researchers explore variations in employment outcomes for people with disabilities
First large study details cognitive outcomes among older breast cancer patients
Long-term antiplatelet monotherapy after stenting is safe but does not improve outcomes
